Should FDA Regulate Nanomedicine Differently?
Friday, June 20th, 2008
Editor’s Note: In an interview published this week, Health Affairs Contributing Editor Barbara Culliton asks Food and Drug Administration (FDA) Associate Commissioner For Science, Norris Alderson, about his agency’s regulation of nanomedicine and the potential for health care cost savings. Here’s an excerpt of their conversation:
Barbara Culliton: Nanomedicine is the “next big thing” in medicine, [...]
Editor’s Note: In an interview published this week, Health Affairs Contributing Editor Barbara Culliton asks Food and Drug Administration (FDA) Associate Commissioner For Science, Norris Alderson, about his agency’s regulation of nanomedicine and the potential for health care cost savings. Here’s an excerpt of their conversation:
Barbara Culliton: Nanomedicine is the “next big thing” in medicine, [...]


